Breaking News Instant updates and real-time market news.

AET

Aetna

$181.31

1.13 (0.63%)

, CVS

CVS Health

$75.12

-1.48 (-1.93%)

08:39
12/04/17
12/04
08:39
12/04/17
08:39

Jefferies sees Aetna trading at 10% discount to deal price

Jefferies analyst David Windley sees Aetna (AET) trading at a 10% spread to the $207 per share price paid by CVS Health (CVS) given the deal's "regulatory hurdles." The analyst sees Aetna trading today to $186 per share. Aetna in premarket trading is up 3%, or $5.99, to $187.30. Windley raised his price target for the stock to $194 from $185 and keeps a Hold rating on the name. The Department of Justice's stance on another major vertical integration, AT&T's (T) acquisition of Time Warner (TWX), suggests the CVS, Aetna transaction could face "significant scrutiny," Windley tells investors in a research note. He believes the regulatory cycle will likely take 9-12 months and may require some Part D divestitures.

AET

Aetna

$181.31

1.13 (0.63%)

CVS

CVS Health

$75.12

-1.48 (-1.93%)

T

AT&T

$36.50

0.12 (0.33%)

TWX

Time Warner

$91.30

-0.21 (-0.23%)

  • 04

    Dec

  • 04

    Dec

  • 04

    Dec

  • 12

    Dec

AET Aetna
$181.31

1.13 (0.63%)

12/04/17
LOOP
12/04/17
NO CHANGE
Target $73
LOOP
Hold
Lower-cost Aetna-CVS healthcare platform may not pan out, says Loop Capital
Loop Capital analyst Andrew Wolf says that while the CVS Health (CVS) acquisition of Aetna (AET) is earnings-accretive with $750M in synergies, the combination will create a highly leveraged enterprise. Wolf also notes that the strategic rationale of a "lower cost vertically integrated healthcare platform" may be compelling in theory, but in practice this expectation may prove to be "illusory" because of the healthcare system that is resistant to institutional change. The analyst keeps his Hold rating on CVS Health with a $73 price target.
12/04/17
SBSH
12/04/17
NO CHANGE
Target $76
SBSH
Neutral
Some may be disappointed in CVS, Aetna synergies, says Citi
Citi analyst Alvin Concepcion says that while he continues to view CVS Health's (CVS) acquisition of Aetna (AET) as favorable for long-term investors, some investors may be disappointed in the "relatively low level" of accretion/synergies combined with a long time-frame and execution risks. Nonetheless, the deal is "both evolutionary and revolutionary," given the dynamic healthcare environment and the need to combat a potential Amazon (AMZN) threat, Concepcion tells investors in a research note. He keeps a Neutral rating on CVS shares with a $76 price target.
12/04/17
COWN
12/04/17
NO CHANGE
Target $81
COWN
Outperform
Cowen generally positive on CVS/Aetna deal
Cowen analyst Charles Ryhee said he is generally positive on CVS' (CVS) deal to purchase Aetna (AET) as it positions CVS for the long-term macro trend of value-based care, which can be better enabled through vertical integration. Ryhee has an Outperform rating and $81 price target on CVS shares.
12/04/17
WELS
12/04/17
NO CHANGE
Target $208
WELS
Outperform
Aetna price target raised to $208 from $200 at Wells Fargo
Wells Fargo raised its price target for Aetna (AET) to $208 from $200 after CVS Health (CVS) announced that it has entered into a definitive agreement to acquire the former for $207 per share. The analyst reiterates an Outperform rating on Aetna's shares.
CVS CVS Health
$75.12

-1.48 (-1.93%)

T AT&T
$36.50

0.12 (0.33%)

11/21/17
BARD
11/21/17
NO CHANGE
Target $42
BARD
Outperform
Merits of antitrust case favor AT&T, says Baird
Baird analyst William Power noted the DOJ sued to block the AT&T (T) and Time Warner (TWX) deal largely on the grounds that the merger would harm consumers due to higher content prices. The analyst finds it difficult to believe that, given other competition, the company would be able to significantly raise pricing for Turner properties or HBO and risk driving away current partners. He said although his thesis is at risk from the suit, he ultimately believes the merits of the case favor AT&T. Power reiterated his Outperform rating and $42 price target on AT&T shares.
11/21/17
NOMU
11/21/17
NO CHANGE
Target $42
NOMU
Buy
AT&T price target lowered to $42 from $45 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal lowered his price for AT&T (T) shares target to $42 after the Justice Department filed a lawsuit to block the company's acquisition of Time Warner (TWX). The analyst notes he didn't lowered his target post the Q3 video miss given the pending deal. He believes the shares have "room to run" with or without Time Warner and keeps a Buy rating on AT&T.
11/21/17
CHLM
11/21/17
NO CHANGE
Target $114
CHLM
Buy
Dycom price target raised to $114 from $90 at Craig-Hallum
Craig-Hallum analyst Christian Schwab raised his price target for Dycom (DY) to $114 from $90 following quarterly results and as the worst of AT&T's (T) spending moderation seems behind it. The analyst reiterates a Buy rating on Dycom's shares.
11/29/17
KEYB
11/29/17
NO CHANGE
KEYB
Q3 results, analysis of Q4 viewership trends show some bright spots, says KeyBanc
KeyBanc analyst Andy Hargreaves notes that the Department of Justice's decision to sue to block AT&T (T)/Time Warner (TWX) seems likely to halt additional M&A until a resolution is reached. Additionally, the analyst points out that Q4 viewership trends appear most positive for Discovery (DISCA), Viacom (VIAB) so far, and 21st Century Fox (FOXA) remains his favorite long among TV network stocks.
TWX Time Warner
$91.30

-0.21 (-0.23%)

11/21/17
WELS
11/21/17
NO CHANGE
Target $84
WELS
Market Perform
Time Warner price target lowered to $84 from $100 at Wells Fargo
Wells Fargo analyst Marci Ryvicker lowered her price target for Time Warner (TWX) to $84 from $100 to reflect standalone value, in light of the recent news that the DOJ will be suing to block the merger with AT&T (T). The analyst reiterates a Market Perform rating on Time Warner's shares.

TODAY'S FREE FLY STORIES

RIGL

Rigel Pharmaceuticals

$3.57

-0.15 (-4.03%)

20:21
12/14/17
12/14
20:21
12/14/17
20:21
Initiation
Rigel Pharmaceuticals initiated at Cantor Fitzgerald »

Rigel Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 17

    Apr

PFE

Pfizer

$36.46

-0.18 (-0.49%)

19:32
12/14/17
12/14
19:32
12/14/17
19:32
Hot Stocks
Pfizer announces FDA approval of Xeljanz »

Pfizer announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

HUSKF

Husky Energy

$12.76

0.3377 (2.72%)

18:44
12/14/17
12/14
18:44
12/14/17
18:44
Upgrade
Husky Energy rating change at Credit Suisse »

Husky Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRAH

PRA Health

$89.13

1.9 (2.18%)

18:41
12/14/17
12/14
18:41
12/14/17
18:41
Initiation
PRA Health initiated at MUFG »

PRA Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$110.57

2.96 (2.75%)

, FOX

21st Century Fox

$34.22

1.88 (5.81%)

18:31
12/14/17
12/14
18:31
12/14/17
18:31
Periodicals
Experts: Disney-Fox deal may raise antitrust worries, Reuters reports »

Competition experts say…

DIS

Disney

$110.57

2.96 (2.75%)

FOX

21st Century Fox

$34.22

1.88 (5.81%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

MESO

Mesoblast

$5.39

-0.07 (-1.28%)

, TIG

TiGenix

$21.67

-2.55 (-10.53%)

18:31
12/14/17
12/14
18:31
12/14/17
18:31
Hot Stocks
Mesoblast grants TiGenix exclusive global license for stem cells treatment »

Mesoblast (MESO) has…

MESO

Mesoblast

$5.39

-0.07 (-1.28%)

TIG

TiGenix

$21.67

-2.55 (-10.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$12.14

0.15 (1.25%)

18:28
12/14/17
12/14
18:28
12/14/17
18:28
Hot Stocks
MiMedx posts new materials on website exposing misinformation from short sellers »

MiMedx announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

, GOOG

Alphabet

$1,049.15

8.54 (0.82%)

18:23
12/14/17
12/14
18:23
12/14/17
18:23
Periodicals
Amazon to begin selling Apple TV, Chromecast on online store, Reuters reports »

Amazon (AMZN) plans to…

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

GOOG

Alphabet

$1,049.15

8.54 (0.82%)

GOOGL

Alphabet Class A

$1,057.47

6.08 (0.58%)

AAPL

Apple

$172.22

-0.05 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 18

    Mar

WM

Waste Management

$84.66

-0.68 (-0.80%)

18:02
12/14/17
12/14
18:02
12/14/17
18:02
Hot Stocks
Waste Management raises quarterly dividend 9.4%, authorizes $1.25B buyback »

Waste Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQV

Iqvia

$101.47

-0.75 (-0.73%)

17:58
12/14/17
12/14
17:58
12/14/17
17:58
Initiation
Iqvia initiated at MUFG »

Iqvia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRE

Sempra Energy

$115.78

0.54 (0.47%)

17:40
12/14/17
12/14
17:40
12/14/17
17:40
Hot Stocks
Sempra Energy, Oncor announce settlement with key stakeholders »

Oncor Electric Delivery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:40
12/14/17
12/14
17:40
12/14/17
17:40
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says FY18 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

, AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

17:34
12/14/17
12/14
17:34
12/14/17
17:34
Hot Stocks
Breaking Hot Stocks news story on Oracle, Amazon.com »

Oracle says switching…

ORCL

Oracle

$50.19

0.14 (0.28%)

AMZN

Amazon.com

$1,174.26

10.13 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Mar

EPD

Enterprise Products

$26.07

0.17 (0.66%)

17:33
12/14/17
12/14
17:33
12/14/17
17:33
Hot Stocks
Enterprise Products to implement further oil quality specifications at Cushing »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:31
12/14/17
12/14
17:31
12/14/17
17:31
Hot Stocks
Adobe 'pleased' with subscription bookings and advertising cloud »

Says photography offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

, COST

Costco

$186.53

-1.75 (-0.93%)

17:30
12/14/17
12/14
17:30
12/14/17
17:30
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Jabil…

JBL

Jabil Circuit

$27.45

-1.08 (-3.79%)

COST

Costco

$186.53

-1.75 (-0.93%)

CNC

Centene

$99.02

-2.17 (-2.14%)

DCIX

Diana Containerships

$4.87

-0.37 (-7.06%)

MS

Morgan Stanley

$52.64

-0.54 (-1.02%)

DDR

DDR Corp.

$7.96

-0.11 (-1.36%)

RMBL

RumbleON

$5.30

-0.06 (-1.12%)

SAH

Sonic Automotive

$20.05

-0.95 (-4.52%)

HES

Hess Corp.

$42.67

-1.43 (-3.24%)

FORM

FormFactor

$14.90

-0.05 (-0.33%)

ORCL

Oracle

$50.19

0.14 (0.28%)

VSTM

Verastem

$3.65

-0.15 (-3.95%)

GBT

Global Blood Therapeutics

$39.40

1.05 (2.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Dec

  • 09

    Jan

AEP

American Electric

$76.29

-0.22 (-0.29%)

17:28
12/14/17
12/14
17:28
12/14/17
17:28
Syndicate
Breaking Syndicate news story on American Electric »

American Electric files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$158.03

-6.62 (-4.02%)

17:25
12/14/17
12/14
17:25
12/14/17
17:25
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Dinner Meeting will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

ORCL

Oracle

$50.20

0.14 (0.28%)

17:24
12/14/17
12/14
17:24
12/14/17
17:24
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Hurd says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:23
12/14/17
12/14
17:23
12/14/17
17:23
Hot Stocks
Adobe targeting subscription bookings growth of 20% in FY18 »

Says expect quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ADBE

Adobe

$175.00

-1.83 (-1.03%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Adobe says advertising cloud had a 'strong' year »

Says advertising cloud…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:20
12/14/17
12/14
17:20
12/14/17
17:20
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle says currency…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

ORCL

Oracle

$50.19

0.14 (0.28%)

17:19
12/14/17
12/14
17:19
12/14/17
17:19
Earnings
Oracle sees Q3 adjusted EPS 68c-70c, consensus 72c »

Sees Q3 revenue growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

, UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

17:17
12/14/17
12/14
17:17
12/14/17
17:17
Hot Stocks
Urstadt Biddle raises quarterly dividend by 0.5c to 27c »

At their regular meeting…

UBA

Urstadt Biddle

$22.71

-0.48 (-2.07%)

UBP

Urstadt Biddle Properties Inc.

$18.00

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

17:14
12/14/17
12/14
17:14
12/14/17
17:14
Hot Stocks
Oracle says customer adoption of cloud products 'remains very strong' »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.